EUVIMEDEUVIMED entdecken
Multizentrische Studie

Direct Antivirals Can Achieve a Cure in All Patients With Chronic Hepatitis C due to Genotype 5: A French Multicentre Study

Carine Nicolas iD, Quentin Domas, Stanislas Pol iD, Edouard Bardou-Jacquet iD, Véronique Loustaud-Ratti, Sophie Métivier, Tarik Asselah, Dominique Thabut iD, Marc Bourlière, Philippe Mathurin, Juliette Foucher, Dominique Larrey und 6 weitere

Liver International · 2025

DOI: 10.1111/liv.16158 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Liver International, 2025. Verfasst von Carine Nicolas und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digestive and Hepatobiliary Medicine, CHU Clermont-Ferrand, Clermont-Ferrand, France. Hauptthemen laut MEDLINE: Antiviral Agents, Hepatitis C, Chronic, Hepacivirus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatitis C virus genotype 5 (HCV‐GT‐5) is found mainly in South Africa. In our area in central France, the prevalence of HCV‐GT‐5 is 14%. Methods and Results Here we evaluated sustained virological response at week 12 post‐treatment (SVR12) in 147 HCV‐GT‐5 patients from 14 French university hospitals (2014–2021) treated with direct‐acting antivirals (DAA) in real‐life. Patients had mainly received sofosbuvir/ledipasvir ± ribavirin, sofosbuvir/velpatasvir, and glecaprevir/pibrentasvir. Overall SVR12 was 98% (144/147). Two patients experienced relapse: one was successfully retreated with the same DAAs (sofosbuvir/ledipasvir) plus ribavirin, and the other refused further DAA treatment. One patient with virological failure (sofosbuvir/velpatasvir) had received a second treatment (sofosbuvir/velpatasvir/voxilaprevir) and progressed to cure.

Conclusions

HCV‐GT‐5 patients treated with a DAA regimen had a 99% SVR12 in intention‐to‐treat (including initial therapy and retreatment) and 100% SVR12 per protocol. Sofosbuvir/ledipasvir, sofosbuvir/velpatasvir, and glecaprevir/pibrentasvir show very good efficacy in real‐world HCV‐GT‐5 patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsHepatitis C, ChronicHepacivirusHumansFranceMaleFemaleMiddle AgedSustained Virologic ResponseGenotypeSofosbuvirPyrrolidinesDrug Therapy, CombinationAgedQuinoxalinesAdultSulfonamidesHeterocyclic Compounds, 4 or More RingsBenzimidazolesRibavirinAminoisobutyric AcidsLactams, MacrocyclicLeucine

Stichwörter der Autor:innen

direct‐acting antiviralgenotype 5hepatitis C virusreal‐worldsustained virological response

Substanzen

Antiviral AgentsSofosbuvirPyrrolidinesQuinoxalinesSulfonamidesHeterocyclic Compounds, 4 or More RingsBenzimidazolesRibavirinvelpatasvirAminoisobutyric Acids

Autor:innen und Institutionen

  • Department of Digestive and Hepatobiliary Medicine, CHU Clermont-Ferrand, Clermont-Ferrand, France.
  • Oncology and Medical-Surgical Specialities, Department of Hepatology, AP-HP/Hôpital Cochin, Paris-Cité University/INSERM U1223-U1016, Paris, France.
  • Department of Liver Diseases, CHU Rennes, Rennes University/UMR124/INSERM CIC1414, Institut NUMECAN, Rennes, France.
  • Department of Hepato-Gastroenterology, CHU Limoges, Limoges University/INSERM U1248, Limoges, France.
  • Department of Hepatology, CHU Toulouse, Toulouse, France.
  • Department of Hepato-Gastroenterology, AP-HP/Hôpital Beaujon, Paris-Cité University/CRI/INSERM UMR1149, Paris, France.

ORCID-Profile: Carine Nicolas, Stanislas Pol, Edouard Bardou-Jacquet, Dominique Thabut

Zitieren

APA

Nicolas, C., Domas, Q., Pol, S., Bardou-Jacquet, E., Loustaud-Ratti, V., Métivier, S., Asselah, T., Thabut, D., Bourlière, M., Mathurin, P., Foucher, J., Larrey, D., Varaut, A., Alric, L., Bailly, F., Muti, L., Buchard, B., & Abergel, A. (2025). Direct Antivirals Can Achieve a Cure in All Patients With Chronic Hepatitis C due to Genotype 5: A French Multicentre Study. Liver International. https://doi.org/10.1111/liv.16158

Vancouver

Nicolas C, Domas Q, Pol S, Bardou-Jacquet E, Loustaud-Ratti V, Métivier S, et al. Direct Antivirals Can Achieve a Cure in All Patients With Chronic Hepatitis C due to Genotype 5: A French Multicentre Study. Liver International. 2025. doi:10.1111/liv.16158

BibTeX
@article{Nicolas2025,
  author = {Nicolas, Carine and Domas, Quentin and Pol, Stanislas and Bardou-Jacquet, Edouard and Loustaud-Ratti, Véronique and Métivier, Sophie and Asselah, Tarik and Thabut, Dominique and Bourlière, Marc and Mathurin, Philippe and Foucher, Juliette and Larrey, Dominique and Varaut, Anne and Alric, Laurent and Bailly, François and Muti, Léon and Buchard, Benjamin and Abergel, Armando},
  title = {Direct Antivirals Can Achieve a Cure in All Patients With Chronic Hepatitis C due to Genotype 5: A French Multicentre Study},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.16158}
}
Kostenlos starten →